Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 4/20 | 0.40 |
| ▸ | FNTB | P49356 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6523925 | 1.00 | FNTA (0.40) | FNTAFNTBALDH1A1DGKAEPHX2 | |
| SCHEMBL6524268 | 0.85 | FAAH (0.45) | ALDH1A1EPHX2TSHRFAAHGAA | |
| SCHEMBL6524274 | 0.85 | FAAH (0.45) | ALDH1A1EPHX2TSHRFAAHGAA | |
| SCHEMBL6519166 | 0.84 | ALDH1A1 (0.40) | FNTAFNTBALDH1A1DGKAEPHX2 | |
| SCHEMBL6520427 | 0.82 | DGKA (0.45) | FNTAFNTBALDH1A1DGKAEPHX2 | |
| SCHEMBL6520435 | 0.82 | DGKA (0.45) | FNTAFNTBALDH1A1DGKAEPHX2 | |
| SCHEMBL6521075 | 0.80 | ALDH1A1 (0.34) | FNTAFNTBALDH1A1DGKATSHR | |
| SCHEMBL6521086 | 0.80 | ALDH1A1 (0.34) | FNTAFNTBALDH1A1DGKATSHR | |
| SCHEMBL6518056 | 0.80 | ALDH1A1 (0.52) | ALDH1A1DGKAEPHX2TSHRTHRB | |
| SCHEMBL6518044 | 0.80 | ALDH1A1 (0.52) | ALDH1A1DGKAEPHX2TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | FNTA 967/4885FNTB 552/4885ALDH1A1 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.